Cite
HARVARD Citation
Tseng, W. et al. (2015). Phase 1 adaptive dose‐finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high‐risk extremity and trunk soft tissue sarcoma. Cancer. 121 (20), pp. 3659-3667. [Online].